Literature DB >> 17406902

Study of tauopathies by comparing Drosophila and human tau in Drosophila.

Xinping Chen1, Yan Li, Junbo Huang, Dawei Cao, Guoying Yang, Weijie Liu, Huimin Lu, Aike Guo.   

Abstract

The microtubule-binding protein tau has been investigated for its contribution to various neurodegenerative disorders. However, the findings from transgenic studies, using the same tau transgene, vary widely among different laboratories. Here, we have investigated the potential mechanisms underlying tauopathies by comparing Drosophila (d-tau) and human (h-tau) tau in a Drosophila model. Overexpression of a single copy of either tau isoform in the retina results in a similar rough eye phenotype. However, co-expression of Par-1 with d-tau leads to lethality, whereas co-expression of Par-1 with h-tau has little effect on the rough eye phenotype. We have found analogous results by comparing larval proteomes. Through genetic screening and proteomic analysis, we have identified some important potential modifiers and tau-associated proteins. These results suggest that the two tau genes differ significantly. This comparison between species-specific isoforms may help to clarify whether the homologous tau genes are conserved.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17406902     DOI: 10.1007/s00441-007-0401-y

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  20 in total

1.  Drosophila Tau Negatively Regulates Translation and Olfactory Long-Term Memory, But Facilitates Footshock Habituation and Cytoskeletal Homeostasis.

Authors:  Katerina Papanikolopoulou; Ilianna G Roussou; Jean Y Gouzi; Martina Samiotaki; George Panayotou; Luca Turin; Efthimios M C Skoulakis
Journal:  J Neurosci       Date:  2019-09-05       Impact factor: 6.167

Review 2.  Human disease models in Drosophila melanogaster and the role of the fly in therapeutic drug discovery.

Authors:  Udai Bhan Pandey; Charles D Nichols
Journal:  Pharmacol Rev       Date:  2011-03-17       Impact factor: 25.468

Review 3.  The power and richness of modelling tauopathies in Drosophila.

Authors:  Katerina Papanikolopoulou; Efthimios M C Skoulakis
Journal:  Mol Neurobiol       Date:  2011-06-17       Impact factor: 5.590

4.  Hsp70 alters tau function and aggregation in an isoform specific manner.

Authors:  Kellen Voss; Benjamin Combs; Kristina R Patterson; Lester I Binder; T Chris Gamblin
Journal:  Biochemistry       Date:  2012-01-23       Impact factor: 3.162

Review 5.  Alzheimer's disease and tauopathy studies in flies and worms.

Authors:  Jill Wentzell; Doris Kretzschmar
Journal:  Neurobiol Dis       Date:  2010-03-17       Impact factor: 5.996

Review 6.  Transgenic Drosophila models of Alzheimer's disease and tauopathies.

Authors:  Kanae Iijima-Ando; Koichi Iijima
Journal:  Brain Struct Funct       Date:  2009-12-05       Impact factor: 3.270

7.  A comparison of the neuronal dysfunction caused by Drosophila tau and human tau in a Drosophila model of tauopathies.

Authors:  Kiren K Ubhi; Hassan Shaibah; Tracey A Newman; David Shepherd; Amritpal Mudher
Journal:  Invert Neurosci       Date:  2007-07-18

8.  Dissociation of tau toxicity and phosphorylation: role of GSK-3beta, MARK and Cdk5 in a Drosophila model.

Authors:  Shreyasi Chatterjee; Tzu-Kang Sang; George M Lawless; George R Jackson
Journal:  Hum Mol Genet       Date:  2008-10-17       Impact factor: 6.150

Review 9.  Drosophila melanogaster as a model organism of brain diseases.

Authors:  Astrid Jeibmann; Werner Paulus
Journal:  Int J Mol Sci       Date:  2009-02-02       Impact factor: 6.208

10.  Loss of axonal mitochondria promotes tau-mediated neurodegeneration and Alzheimer's disease-related tau phosphorylation via PAR-1.

Authors:  Kanae Iijima-Ando; Michiko Sekiya; Akiko Maruko-Otake; Yosuke Ohtake; Emiko Suzuki; Bingwei Lu; Koichi M Iijima
Journal:  PLoS Genet       Date:  2012-08-30       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.